BMS Collaborates with Voluntis to Co-Develop Digital Therapies to Treat Cancer Indications

BMS Collaborates with Voluntis to Co-Develop Digital Therapies for Cancer

Shots:

  • The collaboration will deploy Voluntis’ Theraxium Oncology, a platform for digital therapies in oncology and will evaluate potential solutions to support the management of patients symptoms & remote monitoring by HCPs
  • The focus of the collaboration is to develop digital therapies, providing patients access to a mobile app to support the treatment and track symptoms. The companies will evaluate how digital solutions enable patients to communicate with their HCPs, track symptoms and receive a personalized supportive care plan
  • The app will be developed to entrench evidence-based algorithms intended to provide patients with real-time recommendations for self-management of symptoms regarding therapy

Click here ­to­ read full press release/ article | Ref: BMS | Image: Voluntis